V013-2219 Screening compound: methyl 2-{1-[2-(2,4-dichlorobenzamido)-1,3-thiazol-4-yl]-N-methylformamido}acetate

V013-2219 Screening compound: methyl 2-{1-[2-(2,4-dichlorobenzamido)-1,3-thiazol-4-yl]-N-methylformamido}acetate
V013-2219 Screening compound: methyl 2-{1-[2-(2,4-dichlorobenzamido)-1,3-thiazol-4-yl]-N-methylformamido}acetate alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-2219
methyl 2-{1-[2-(2,4-dichlorobenzamido)-1,3-thiazol-4-yl]-N-methylformamido}acetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-2219

Molecular Formula

C15H13Cl2N3O4S (C15 H13 Cl2 N3 O4 S)

Compound Name

methyl 2-{1-[2-(2,4-dichlorobenzamido)-1,3-thiazol-4-yl]-N-methylformamido}acetate

IUPAC name

methyl 2-{1-[2-(24-dichlorobenzamido)-13-thiazol-4-yl]-N-methylformamido}acetate

SMILES

CN(CC(OC)=O)C(c1csc(NC(c(ccc(Cl)c2)c2Cl)=O)n1)=O

InChI

InChI=1S/C15H13Cl2N3O4S/c1-20(6-12(21)24-2)14(23)11-7-25-15(18-11)19-13(22)9-4-3-8(16)5-10(9)17/h3-5,7H,6H2,1-2H3,(H,18,19,22)

InChI Key

GRTZNFQCHIAHHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19976272

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

402.26

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.952

Distribution Coefficient, logD

1.923

Water Solubility, LogSw

-3.71

Polar Surface Area

70.377

Acid Dissociation Constant (pKa)

6.41

Base Dissociation Constant (pKb)

-4.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

V013-2219 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V013-2219 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-2219?
Check Price and Availability of V013-2219, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-2219 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-2219
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-2219
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-2219 available by request